DexCom Inc (DXCM NASDAQ) stock market data APIs
$60.8129
-0.1(-0.2%)
as of May 1, 2026
Try our APIs with
free plan!
DexCom Inc Financial Data Overview
Price chart is built with
Anychart
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Prev. Close
60.8129
Open
60.715
High
62.5907
Low
60.147
52 wk Range
54.11-89.98
Market Cap
23 673 M
P/E Ratio
26.3305
Shares Outstanding
386 M
Revenue
4 818 M
EPS
0.56
Beta
1.556
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with DexCom Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DexCom Inc data using free add-ons & libraries
Get DexCom Inc Fundamental Data
DexCom Inc Fundamental data includes:
- Net Revenue: 4 818 M
- EBITDA: 1 292 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-04-23
- EPS/Forecast: 0.472
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DexCom Inc News
New
DexCom Medicare Coverage NCD Remains Biggest 2026 Catalyst, RBC Says
DexCom (DXCM) added record new patient starts globally in Q1, while the Continuous Glucose Monitorin PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
ITGR Stock Up Despite Q1 Earnings Missing Estimates, Revenues Rise Y/Y
Integer Holdings Corporation ITGR delivered adjusted earnings per share (EPS) of $1.20 in the first quarter of 2026, which declined 8.4% year over year. The figure missed the Zacks Consensus Estimate...
DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise
DexCom, Inc. DXCM reported first-quarter 2026 adjusted earnings per share (EPS) of 56 cents, which beat the Zacks Consensus Estimate of 47 cents by 19.2%. The company reported adjusted EPS of 32 cent...
Stocks making the biggest moves premarket: Apple, Estee Lauder, Roku, Reddit, Roblox and more
Check out the companies making the biggest moves premarket: Apple — Shares were up 3.5%. For the fiscal second quarter , Apple's earnings came in at $2.01 per share, while revenue landed at $111.18 ...
Get DexCom Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
